Erso Capital, the fund founded by risk specialists Thomas Miller and TheJudge, reports that it has vetted over 250 case opportunities since its launch in February and has made investments in a wide variety of cases with capital requirements ranging from USD $500.0 thousand to USD $12.0 million. Read more.
Erso Capital, a litigation funder which launched 18 months ago, says it has $500 million to invest in patent disputes in the UK and the US, explaining that the decision to create an additional capital pool specifically for patent litigation was borne out of the high demand, especially across both tech and life sciences sectors.
Sarah Breckenridge of Erso Capital notes that it has become market practice – in competition claims but more widely in litigation – to require claimants to obtain (at further cost) an Anti-Avoidance Endorsement or deed of indemnity in favour of the defendant to augment an ATE policy but explains how, in the recent case against Qualcomm, the claimant’s lawyers were able to convince the Competition Appeal Tribunal that this extra insurance was not necessary in Consumers’ Association V Qualcomm Incorporated: Preparing To Fight On Anti-Avoidance Endorsements.
The former owners of litigation insurance broker TheJudge Group have launched a new litigation finance fund with the Thomas Miller Group following the latter’s acquisition of the broker last year. The new fund – Erso Capital – will have access to more than $1bn of capital through its discretionary funds, single managed accounts and co-investment funds. The fund will be led by founders and former TheJudge owners Matthew Amey, James Blick and James Delaney.
We’ll alert you to key situations and stories you should be aware of.
We deliver the important litigation finance news and analysis straight to your inbox each Monday morning.
The newsletter is always free.
